Regulatory snapshots, including drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations in Asia-Pacific: Alphamab Oncology, Beigene, Biontech, Canbridge, Cstone, I-Mab, Innocare, Johnson & Johnson, Kintor, Moderna, Moleculin, Nanolek, Neuren, Pfizer, Shenzhen Chipscreen.